« Previous
Next »
Titles
- Reductions in deaths and hospitalizations associated with COVID-19 vaccinations among Medicare beneficiaries: full year 2021 estimates2
- Technical specifications for submitting clinical trial data sets for treatment of noncirrhotic nonalcoholic steatohepatitis (NASH)2
- Understanding coverage considerations for COVID-19 vaccines and treatments2
- A call for federal action to improve nursing facilities1
- A resource guide for using Medicare’s enrollment race and ethnicity data1
- A risk-based approach to monitoring of clinical investigations questions and answers: guidance for industry1
- A single-payer health care system that is based on Medicare’s fee-for-service program: testimony before the Committee on the Budget, United States Senate1
- A state roadmap1
- ACF should improve oversight of head start to better protect children’s safety1
- Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate1
- Access to preventive services without cost-sharing: evidence from the Affordable Care Act1
- Achieving behavioral health care integration in rural America1
- Action level for inorganic arsenic in apple juice: guidance for industry1
- Acute myeloid leukemia: developing drugs and biological products for treatment : guidance for industry1
- Addressing social determinants of health: examples of successful evidence-based strategies and current federal efforts1
- Addressing the direct care workforce shortage: a bipartisan call to action1
- Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry1
- Advanced prostate cancer: developing gonadotropin-releasing hormone analogues1
- Advancing primary prevention in human services. Key considerations for administrators and practitioners1
- Advancing primary prevention in human services. Key considerations for policy designers and funding partners1